Home › Merck Animal Health Pioneers H3N2 Canine Influenza Vaccine
 

Keywords :   


Merck Animal Health Pioneers H3N2 Canine Influenza Vaccine

2015-11-20 22:00:08| Merck.com - Corporate News

Dateline City: MADISON, N.J. Innovative Addition Further Strengthens CIV Product Line Madison, N.J. - In response to the H3N2 canine influenza (CIV) outbreaks that impacted dogs in 241 states, Merck Animal Health (known as MSD Animal Health outside the United States and Canada) today announced the U.S. Department of Agriculture (USDA) has issued a conditional product license for a vaccine to protect against this newly identified strain of CIV. Canine Influenza Vaccine H3N2 will be available to U.S. veterinarians beginning Monday, November 23. Language: English read more

Tags: health animal vaccine pioneers

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.11Tropical Storm Lane Graphics
02.11Subtropical Storm Patty Graphics
02.11Tropical Storm Lane Forecast Discussion Number 4
02.11Subtropical Storm Patty Wind Speed Probabilities Number 2
02.11Summary for Tropical Storm Lane (EP3/EP132024)
02.11Subtropical Storm Patty Public Advisory Number 2
02.11Subtropical Storm Patty Forecast Advisory Number 2
02.11Subtropical Storm Patty Update Statement
More »